Cerus (CERS) Corporation announced two in-country regulatory approvals for INT200, its next-generation LED-based illumination device. The approvals were from the French National Agency for Medicines and Health Product Safety and the Swiss Agency for Therapeutic Products. These approvals follow the CE Mark authorization received in March. Cerus expects to convert its installed base of INT100s in EMEA to INT200s over the next three years and plans a PMA submission to the FDA during 2026.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERS: